Novavax Gets First Sell Rating Since 2020. It's Got a Covid Vaccine Problem, Analyst Says.Barrons • 05/20/22
4 Growth Stocks Billionaire Money Managers Piled Into During the First QuarterThe Motley Fool • 05/19/22
Stock Market Plunge: 5 Discounted Growth Stocks to Buy Now and Hold ForeverThe Motley Fool • 05/10/22
Novavax, Inc. (NVAX) CEO Stan Erck on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22